Verapamil (Calan, Verelan) and Ketamine Therapy | Tovani Health
Calan (Verapamil) (also: Verelan, Isoptin) — Non-dihydropyridine calcium channel blocker (CYP3A4 inhibitor)
Verdict at Tovani Health
Compatible; CYP3A4 inhibition similar to diltiazem, modest effect on ketamine levels.
Verapamil and ketamine are compatible. Same considerations as diltiazem: moderate CYP3A4 inhibition can modestly raise ketamine exposure. Verapamil also has stronger negative inotropic and chronotropic effects, which makes the cardiovascular picture marginally more complex but not problematic for KAP.
If you take Calan regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How Calan interacts with ketamine
Verapamil inhibits L-type calcium channels and CYP3A4 (moderate). Used for arrhythmias, hypertension, migraine prophylaxis, and cluster headache.
What we do at intake
Disclose dose and indication. Continue as normal. BP and HR are monitored during the session.
Bottom line
Verapamil and ketamine are compatible. Same considerations as diltiazem: moderate CYP3A4 inhibition can modestly raise ketamine exposure. Verapamil also has stronger negative inotropic and chronotropic effects, which makes the cardiovascular picture marginally more complex but not problematic for KAP.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Calan (Verapamil) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthetic and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Clinical Pharmacokinetics. 2016. PMID: 27028535
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 17, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.